Correlation Between Inhibrx and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Mink Therapeutics, you can compare the effects of market volatilities on Inhibrx and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Mink Therapeutics.
Diversification Opportunities for Inhibrx and Mink Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Mink is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Mink Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 1.29 times more return on investment than Mink Therapeutics. However, Inhibrx is 1.29 times more volatile than Mink Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,595 in Inhibrx on September 1, 2024 and sell it today you would lose (69.00) from holding Inhibrx or give up 4.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Mink Therapeutics
Performance |
Timeline |
Inhibrx |
Mink Therapeutics |
Inhibrx and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Mink Therapeutics
The main advantage of trading using opposite Inhibrx and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |